-+ 0.00%
-+ 0.00%
-+ 0.00%

Cartesian Therapeutics shareholders elect Class I director slate at annual meeting

PUBT·06/17/2026 20:02:04
Listen to the news
Cartesian Therapeutics shareholders elect Class I director slate at annual meeting
  • Cartesian Therapeutics held its annual shareholder meeting on June 12, 2026.
  • Shareholders selected three Class I directors to serve through the 2029 annual meeting.
  • Shareholders ratified Ernst & Young as independent registered public accounting firm for the year ending Dec. 31, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cartesian Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001453687-26-000090), on June 17, 2026, and is solely responsible for the information contained therein.